8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of Earliest Event Reported):    November 30, 2005 (November 30, 2005)

ALLIED HEALTHCARE INTERNATIONAL INC.
(Exact Name of Registrant as Specified on its Charter)

1-11570				13-3098275
(Commission File Number)				(IRS Employer Identification Number)

                                                New York                                                
(State or Other Jurisdiction of Incorporation or Organization)

555 Madison Avenue, New York, New York 10022
(Address of Principal Executive Offices)

                                    (212) 750-0064                                    
(Registrant's Telephone Number, Including Area Code)

                                                                                                                        
(Former Name or Former Address, If Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provision:

            Written communications pursuant to Rule 425 under the Securities Act.

            Soliciting material pursuant to Rule 14a-12 under the Exchange Act.

            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

ITEM 8.01    OTHER EVENTS.

On November 30, 2005 Allied Healthcare International Inc. (the Company") issued a press release announcing that it had applied to have its common stock listed on the Alternative Investment Market (AIM) of the London Stock Exchange. AIM is a market designed primarily for emerging or smaller companies. A copy of the press release, as well as the AIM listing application, which is entitled "AIM Schedule 1—Pre-Admission Announcement", is attached to this Form 8-K.

The Company is not issuing any additional shares of common stock or other securities in connection with the proposed listing on AIM. Acceptance of the application will create a dual listing for the common stock of the Company on the Nasdaq National Market and AIM. The listing of the common stock of the Company on AIM is expected to become effective on or about December 30, 2005, although there can be no assurance to such effect.

ITEM 9.01    FINANCIAL STATEMENTS AND EXHIBITS

99.1    Press release, dated November 30, 2005, of Allied Healthcare International Inc.

99.2	AIM Schedule 1—Pre-Admission Announcement filed by Allied Healthcare International Inc. with the Alternative Investment Market of the London Stock Exchange.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: November 30, 2005

ALLIED HEALTHCARE INTERNATIONAL INC.

By: /s/ Marvet Abbassi

Name: Marvet Abbassi
Title: Financial Controller

2

EX-99.1

     Allied Healthcare Applies for London Stock Exchange AIM Listing

     NEW YORK--Nov. 30, 2005--Allied Healthcare International Inc. (Nasdaq:
AHCI), a leading provider of flexible healthcare staffing services in the United
Kingdom, announces that it has applied to be listed on the Alternative
Investment Market (AIM) of the London Stock Exchange. This application will
create a dual listing for Allied Healthcare on the NASDAQ and AIM and is
expected to be effective on or about December 30, 2005.

     Tim Aitken, Allied Healthcare CEO commented, "Listing our company on AIM
makes sense given our business currently operates principally in the U.K. This
dual listing will benefit shareholders on both sides of the Atlantic and will
give the Company greater access to those U.K. institutional investors who are
currently unable to hold U.S. listed stocks."

     About the Alternative Investment Market (AIM)

     AIM is one of the world's leading markets for smaller companies. Since its
launch in 1995, over 1,900 companies have chosen to join AIM from all over the
world, creating a unique community of innovative and entrepreneurial companies.
Aim's success is built on a simplified regulatory environment, which has been
specifically designed for the needs of smaller companies.

     ABOUT ALLIED HEALTHCARE INTERNATIONAL INC.

     Allied Healthcare International Inc. (http://www.alliedhealthcare.com) is a
leading provider of flexible healthcare staffing services in the United Kingdom.
Allied operates a community-based network of approximately 110 branches with the
capacity to provide carers (known as home health aides in the U.S.), nurses, and
specialized medical personnel to locations covering approximately 90% of the
U.K. population. Allied meets the needs of Private Patients, Community Care,
Nursing Homes and Hospitals. The Company also supplies medical-grade oxygen for
use in respiratory therapy in the U.K. pharmacy market and to private patients
in Northern Ireland.



     FORWARD-LOOKING STATEMENTS

     Certain statements contained in this news release may be forward-looking
statements. These forward-looking statements are based on current expectations
and projections about future events. Actual results could differ materially from
those discussed in, or implied by, these forward-looking statements. Factors
that could cause actual results to differ from those implied by the
forward-looking statements include: Allied's ability to continue to recruit and
retain qualified flexible healthcare staff; ability to enter into contracts with
hospitals and other healthcare facility customers on terms attractive to Allied;
the general level of patient occupancy at hospital and healthcare facilities of
Allied's customers; the ability to successfully implement acquisition and
integration strategies; dependence on the proper functioning of Allied's
information systems; the effect of existing or future government regulation of
the healthcare industry, and ability to comply with these regulations; the
impact of medical malpractice and other claims asserted against Allied; the
effect of regulatory change that may apply to Allied and that may increase costs
and reduce revenue and profitability; the ability to use net operating loss
carry forwards to offset net income; and the impairment of goodwill, of which
Allied has a substantial amount on the balance sheet, may have the effect of
decreasing earnings or increasing losses. Other factors that could cause actual
results to differ from those implied by the forward-looking statements in this
press release include those described in Allied's most recently filed SEC
documents, such as its most recent annual report on Form 10-K, all quarterly
reports on form 10-Q and any current reports on Form 8-K filed since the date of
the last Form 10-K. Allied undertakes no obligation to publicly update or revise
any forward-looking statements, whether as a result of new information, future
events or otherwise.

     CONTACT: Allied Healthcare International Inc.
     Charles Murphy, 212-750-0064
     charlesmurphy@alliedhealthcare.com
     or
     Investors:
     The Investor Relations Group
     Adam Holdsworth / John Nesbett, 212-825-3210

EX-99.2

AIM   SCHEDULE 1 - PRE-ADMISSION ANNOUNCEMENT

PLEASE FORWARD THIS FORM TO AIMREGULATION@LONDONSTOCKEXCHANGE.COM
IN THE CASE OF QUERIES PLEASE CONTACT AIM ON +44 (0) 20 7797 4154

- --------------------------------------------------------------------------------
       ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN
                           ACCORDANCE WITH AIM RULE 2
- --------------------------------------------------------------------------------

- --------------------------------------------------------------------------------
ALL APPLICANTS MUST COMPLETE THE FOLLOWING:
- --------------------------------------------------------------------------------

- --------------------------------------------------------------------------------
COMPANY NAME:
- --------------------------------------------------------------------------------
Allied Healthcare International Inc. (the "Company")

- --------------------------------------------------------------------------------
COMPANY ADDRESS:
- --------------------------------------------------------------------------------
555 Madison Avenue
New York
New York
USA

- --------------------------------------------------------------------------------
COMPANY POSTCODE:
- --------------------------------------------------------------------------------
10022

- --------------------------------------------------------------------------------
COUNTRY OF INCORPORATION:
- --------------------------------------------------------------------------------
USA

- --------------------------------------------------------------------------------
COMPANY BUSINESS OR, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS
INVESTMENT STRATEGY TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE 2, PARAGRAPH (J)
OF THE AIM RULES:
- --------------------------------------------------------------------------------
Allied Healthcare International Inc. is a provider of temporary staffing to the
UK healthcare industry, principally nurses, nurse aides and home health aides.

- --------------------------------------------------------------------------------
DETAILS OF SECURITIES TO BE ADMITTED (i.e. where known, number of shares,
nominal value and issue price to which it seeks admission and the number and
type to be held as treasury shares):
- --------------------------------------------------------------------------------
44,855,772 shares of common stock of $0.01 each (plus 584,755 shares of common
stock of $0.01 each held in treasury)

- --------------------------------------------------------------------------------
CAPITAL TO BE RAISED ON ADMISSION:
- --------------------------------------------------------------------------------
Nil

- --------------------------------------------------------------------------------
FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS:
- --------------------------------------------------------------------------------
Timothy Maxwell Aitken          Chairman and Chief Executive Officer
Sarah Ladd Eames                Executive Vice President and Director
George Richard Green            Non-Executive Director
Mark Steven Hanley              Non-Executive Director
Wayne Anthony Palladino         Non-Executive Director
Jeffrey Scott Peris             Non-Executive Director
Scott Aaron Shay                Non-Executive Director
Henry John Mark Tompkins        Non-Executive Director






- --------------------------------------------------------------------------------
PERSON(S) INTERESTED IN 3% OR MORE OF THE ISSUER'S CAPITAL, EXPRESSED AS A
PERCENTAGE OF THE ISSUED SHARE CAPITAL BEFORE AND AFTER ADMISSION:
- --------------------------------------------------------------------------------
Before and after admission:
Timothy Aitken                                                4.5%
Washington & Congress Capital Partners, L.P.                  17.2%
Lewis S. Ranieri*                                             26.8%
Scott A. Shay*                                                26.7%
Hyperion Partners II L.P*                                     26.7%
Hyperion TW Fund L.P. *                                       26.7%
Hyperion TWH Fund LLC*                                        26.7%
Hyperion TWH Fund II LLC*                                     26.7%

* Mr. Ranieri and Mr. Shay are affiliates of Hyperion Partners II L.P., Hyperion
TW Fund L.P., Hyperion TWH Fund LLC and Hyperion TWH Fund II LLC (together, the
"Hyperion Funds") and the Hyperion Funds are affiliates of one another under
applicable US securities rules.

- --------------------------------------------------------------------------------
NAMES AND ADDRESSES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE
2, PARAGRAPH (H) OF THE AIM RULES:
- --------------------------------------------------------------------------------
In the year to 29 November 2005 Nina Temple Cox was paid (pound)127,150 for
marketing consultancy services provided to the Company. Jenny Mayes was paid
(pound)30,000 for consultancy services provided to the Company. Neither Nina
Temple Cox nor Jenny Mayes has any relationship with the Company save for the
consultancy arrangements described above.

- --------------------------------------------------------------------------------
ANTICIPATED ACCOUNTING REFERENCE DATE:
- --------------------------------------------------------------------------------
30 September

- --------------------------------------------------------------------------------
EXPECTED ADMISSION DATE:
- --------------------------------------------------------------------------------
30 December 2005

- --------------------------------------------------------------------------------
NAME AND ADDRESS OF NOMINATED ADVISER:
- --------------------------------------------------------------------------------
KBC Peel Hunt Ltd
111 Old Broad Street
London
EC2N 1PH

- --------------------------------------------------------------------------------
NAME AND ADDRESS OF BROKER:
- --------------------------------------------------------------------------------
KBC Peel Hunt Ltd
111 Old Broad Street
London
EC2N 1PH


- --------------------------------------------------------------------------------
DETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE
AVAILABLE FROM, WITH A STATEMENT THAT THIS WILL CONTAIN FULL DETAILS ABOUT THE
APPLICANT AND THE ADMISSION OF ITS SECURITIES:
- --------------------------------------------------------------------------------
N/A (quoted applicant)

- --------------------------------------------------------------------------------
DATE OF NOTIFICATION:
- --------------------------------------------------------------------------------
29 November 2005




- --------------------------------------------------------------------------------
NEW/ UPDATE (see note):
- --------------------------------------------------------------------------------
NEW

- --------------------------------------------------------------------------------
QUOTED APPLICANTS MUST ALSO COMPLETE THE FOLLOWING:
- --------------------------------------------------------------------------------

- --------------------------------------------------------------------------------
THE NAME OF THE AIM DESIGNATED MARKET UPON WHICH THE APPLICANT'S SECURITIES HAVE
BEEN TRADED:
- --------------------------------------------------------------------------------
NASDAQ

- --------------------------------------------------------------------------------
THE DATE FROM WHICH THE APPLICANT'S SECURITIES HAVE BEEN SO TRADED:
- --------------------------------------------------------------------------------
23 February 2004


- --------------------------------------------------------------------------------
CONFIRMATION THAT, FOLLOWING DUE AND CAREFUL ENQUIRY, THE APPLICANT HAS ADHERED
TO ANY LEGAL AND REGULATORY REQUIREMENTS INVOLVED IN HAVING ITS SECURITIES
TRADED UPON SUCH A MARKET:
- --------------------------------------------------------------------------------
The directors of Allied Healthcare International Inc. confirm that after due and
careful enquiry Allied Healthcare International Inc. has adhered to all legal
and regulatory requirements involved in having its securities traded on NASDAQ.

Refer also to appendix under "AIM Admission" at www.alliedhealthcare.com.
                                                ------------------------

- --------------------------------------------------------------------------------
AN ADDRESS OR WEB-SITE ADDRESS WHERE ANY DOCUMENTS OR ANNOUNCEMENTS WHICH THE
APPLICANT HAS MADE PUBLIC OVER THE LAST TWO YEARS (IN CONSEQUENCE OF HAVING ITS
SECURITIES SO TRADED) ARE AVAILABLE:
- --------------------------------------------------------------------------------
www.sec.gov
- -----------

- --------------------------------------------------------------------------------
DETAILS OF THE APPLICANT'S STRATEGY FOLLOWING ADMISSION INCLUDING, IN THE CASE
OF AN INVESTING COMPANY, DETAILS OF ITS INVESTMENT STRATEGY:
- --------------------------------------------------------------------------------
The Company intends to expand its range of healthcare staffing services over the
long term. It intends to do this by the acquisition of complementary UK
healthcare staffing businesses. The Company also intends to evaluate
opportunities to acquire healthcare staffing businesses in the USA.

- --------------------------------------------------------------------------------
A DESCRIPTION OF ANY SIGNIFICANT CHANGE IN FINANCIAL OR TRADING POSITION OF THE
APPLICANT, WHICH HAS OCCURRED SINCE THE END OF THE LAST FINANCIAL PERIOD FOR
WHICH AUDITED STATEMENTS HAVE BEEN PUBLISHED:
- --------------------------------------------------------------------------------
There has been no significant change in the financial or trading position of the
Company since 30 September 2005, which is the end of the last financial period
for which audited statements have been published.









- --------------------------------------------------------------------------------



- --------------------------------------------------------------------------------
A STATEMENT THAT THE DIRECTORS OF THE APPLICANT HAVE NO REASON TO BELIEVE THAT
THE WORKING CAPITAL AVAILABLE TO IT OR ITS GROUP WILL BE INSUFFICIENT FOR AT
LEAST TWELVE MONTHS FROM THE DATE OF ITS ADMISSION:
- --------------------------------------------------------------------------------
The Directors have no reason to believe that the working capital available to
the Company or its group will be insufficient for at least twelve months from
the date of its admission.

Refer also to paragraph 7 of the appendix under "AIM Admission" at
www.alliedhealthcare.com
- ------------------------

- --------------------------------------------------------------------------------
DETAILS OF ANY LOCK-IN ARRANGEMENTS PURSUANT TO RULE 7 OF THE AIM RULES:
- --------------------------------------------------------------------------------
N/A

- --------------------------------------------------------------------------------
A BRIEF DESCRIPTION OF THE ARRANGEMENTS FOR SETTLING THE APPLICANT'S SECURITIES:
- --------------------------------------------------------------------------------
As foreign securities cannot be settled through the CREST system, the Company
has appointed Computershare Investor Services plc to act as depositary and
Computershare Investor Services plc will issue depositary interests to the
shareholders. Computershare Investor Services plc will apply for these
depositary interests to be admitted to the CREST settlement system with effect
from admission. Refer to paragraph 5 in the appendix under "AIM Admission" at
www.alliedhealthcare.com.


- --------------------------------------------------------------------------------
A WEBSITE ADDRESS DETAILING THE RIGHTS ATTACHING TO THE APPLICANT'S SECURITIES:
- --------------------------------------------------------------------------------
www.alliedhealthcare.com under "AIM Admission"
- ------------------------

- --------------------------------------------------------------------------------
INFORMATION EQUIVALENT TO THAT REQUIRED FOR AN ADMISSION DOCUMENT WHICH IS NOT
CURRENTLY PUBLIC:
- --------------------------------------------------------------------------------
Refer to appendix under "AIM Admission" at www.alliedhealthcare.com
                                           ------------------------

- --------------------------------------------------------------------------------
A WEBSITE ADDRESS OF A PAGE CONTAINING THE APPLICANT'S LATEST ANNUAL REPORT AND
ACCOUNTS WHICH MUST HAVE A FINANCIAL YEAR END NOT MORE THEN NINE MONTHS PRIOR TO
ADMISSION AND FULLY AUDITED INTERIM RESULTS WHERE APPLICABLE. THE ACCOUNTS MUST
BE PREPARED ACCORDING TO UK OR US GAAP OR INTERNATIONAL ACCOUNTING STANDARDS:
- --------------------------------------------------------------------------------
www.alliedhealthcare.com
- ------------------------

- --------------------------------------------------------------------------------
THE NUMBER OF EACH CLASS OF SECURITIES HELD IN TREASURY:
- --------------------------------------------------------------------------------
584,755 shares of common stock of $0.01

- --------------------------------------------------------------------------------

Note: THIS FIELD SHOULD INDICATE THAT THE ANNOUNCEMENT IS `NEW' AND ALL RELEVANT
FIELDS SHOULD BE COMPLETED. OTHERWISE WHERE THE FORM IS REQUIRED TO BE COMPLETED
IN RESPECT OF AN `UPDATE' ANNOUNCEMENT, THIS SHOULD BE INDICATED. IN SUCH CASES,
ALL THE ORIGINAL INFORMATION SHOULD BE INCLUDED WITH ANY AMENDED FIELDS
EMBOLDENED.